Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Home urine test could revolutionise prostate cancer diagnosis
Dr Jeremy Clark, from University of East Anglia's Norwich Medical School, has said the move could "revolutionise diagnosis".
In a first for cell biology, scientists observe ribosome assembly in real time
A team of scientists from Scripps Research and Stanford University has recorded in real time a key step in the assembly of ribosomes—the complex and evolutionarily ancient "molecular machines&q...
Popular heartburn drugs may up odds of stomach bug
(HealthDay)—If you're one of the millions who rely on medications known as proton pump inhibitors for relief from heartburn, you may be at higher risk of illness from a stomach bug, new ...
FDA accepts Incyte’s NDA for priority review of pemigatinib to treat cholangiocarcinoma
The US Food and Drug Administration (FDA) has accepted Incyte’s new drug application (NDA) for the priority review of its pemigatinib to treat patients with cholangiocarcinoma.
One shot of ketamine could reduce problem drinking
A one-off dose of ketamine could help heavy drinkers reduce their alcohol intake, finds a new UCL experimental study.
Asahi Kasei Unveils Deal to Buy Veloxis for $1.3 Billion
Asahi Kasei Corp.
Teva partners with Israeli institutes for early-stage drug research
JERUSALEM (Reuters) - Teva Pharmaceutical Industries on Monday signed research agreements with two leading Israeli academic institutes, a move to boost its early-stage drug development with a ...
Activation of opioid receptor uncovered
Together with colleagues from Shanghai, Brussels, Canada and the USA, researchers from the University of Bonn have uncovered the binding mechanism of an important pain receptor.
New migraine medications could endanger patients with high blood pressure
New migraine medications block αCGRP, a neuropeptide which causes vasodilation, for example in the meninges.
Using artificial intelligence to determine whether immunotherapy is working
CLEVELAND--Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy will be successfu...
Blackstone to invest $400 million in gene therapy venture with Ferring
(Reuters) - Blackstone Group Inc (BX.
Newron Receives FDA Rare Pediatric Disease Designation for Sarizotan for the Treatment of Rett Syndrome
MILAN & MORRISTOWN, N.
341
342
343
344
345
346
347
348
349
